Suppr超能文献

肿瘤特征对肝细胞癌患者肝移植结局的影响。

Impact of tumor characteristic on the outcome of liver transplantation in patients with hepatocellular carcinoma.

作者信息

Dudek K, Kornasiewicz O, Remiszewski P, Kobryń K, Ziarkiewicz-Wróblewska B, Górnicka B, Zieniewicz K, Krawczyk M

机构信息

Department of General, Transplant and Liver Surgery, Medical University of Warsaw, Banacha 1a, 02-097 Warsaw, Poland.

出版信息

Transplant Proc. 2009 Oct;41(8):3135-7. doi: 10.1016/j.transproceed.2009.08.016.

Abstract

INTRODUCTION

Orthotopic liver transplantation (OLT) is a well-established treatment for cirrhotic patients with hepatocellular carcinoma (HCC) who meet the Milan criteria. The aim of this study was to identify predictors of survival among 65 patients with HCC in cirrhotic livers who underwent liver transplantation (OLT).

METHODS

From January 2001 to December 2008, we performed 655 OLT in 615 patients. HCC was diagnosed in 58 patients before OLT and in 65 by histological examination of the explanted livers; 74% of the patients met Milan criteria by histological examination.

RESULTS

The median follow-up was 27 months (range = 1-96). We analyzed patient age and gender, etiology of liver disease, Child score at transplantation, rejection episodes, tumor number/size, vascular invasion, and differentiation grade. There was no significant difference in survival among patients grouped according to the Model for End-stage Liver Disease staging system for HCC. The 5-year survival of patients with low differentiated (G3) HCC was significantly worse than that of those with moderately differentiated (G2) or well-differentiated (G1) HCC: 50%, 81%, and 86% respectively, (P < .01). Patients with microvascular invasion displayed a worse 5-year survival than those without vascular invasion (42% vs 80%; P < .01).

CONCLUSIONS

The analysis indicated that the histological grade of the tumors and evidences of microscopic vascular invasion were the most useful predictive factors for overall survival among patients with cirrhosis after liver transplantation for HCC.

摘要

引言

原位肝移植(OLT)是治疗符合米兰标准的肝硬化肝细胞癌(HCC)患者的一种成熟疗法。本研究的目的是确定65例接受肝移植(OLT)的肝硬化肝脏HCC患者的生存预测因素。

方法

2001年1月至2008年12月,我们对615例患者进行了655例OLT。58例患者在OLT前被诊断为HCC,65例通过移植肝组织学检查确诊;74%的患者经组织学检查符合米兰标准。

结果

中位随访时间为27个月(范围=1 - 96个月)。我们分析了患者的年龄和性别、肝病病因、移植时的Child评分、排斥反应、肿瘤数量/大小、血管侵犯和分化程度。根据终末期肝病模型分期系统对HCC患者进行分组,各组患者的生存率无显著差异。低分化(G3)HCC患者的5年生存率显著低于中分化(G2)或高分化(G1)HCC患者:分别为50%、81%和86%,(P <.01)。有微血管侵犯的患者5年生存率低于无血管侵犯的患者(42%对80%;P <.01)。

结论

分析表明,肿瘤的组织学分级和微血管侵犯证据是HCC肝移植后肝硬化患者总体生存最有用的预测因素。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验